Literature DB >> 10088621

Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression.

P Mukherjee1, A V Sotnikov, H J Mangian, J R Zhou, W J Visek, S K Clinton.   

Abstract

BACKGROUND: A sedentary lifestyle coupled with excessive energy intake is speculated to be a factor associated with increased incidence of prostate cancer. We have investigated the effects of energy intake on prostate tumor growth in experimental animals.
METHODS: Two transplantable prostate tumor models, i.e., the androgen-dependent Dunning R3327-H adenocarcinoma in rats and the androgen-sensitive LNCaP human carcinoma in severe combined immunodeficient mice, were studied. R3327-H tumor growth and relevant tumor biomarkers (proliferation index, apoptosis [programmed cell death], microvessel density, and vascular endothelial growth factor [VEGF] expression) were compared in ad libitum fed control rats, ad libitum fed castrated rats, and groups restricted in energy intake by 20% or 40%. A second set of experiments involving both tumor models examined tumor growth in ad libitum fed rats or in animals whose energy intake was restricted by 30% using three different methods, i.e., total diet restriction, carbohydrate restriction, or lipid restriction. All P values are two-sided.
RESULTS: R3327-H tumors were smaller in energy-restricted or castrated rats than in control rats (P<.001). Tumors from energy-restricted rats exhibited changes in tumor architecture characterized by increased stroma and more homogeneous and smaller glands. In castrated rats, the tumor proliferation index was reduced (P<.0001), whereas apoptosis was increased in both energy-restricted (P<.001) and castrated (P<.001) rats. Tumor microvessel density and VEGF expression were reduced by energy restriction and castration (P<.003 versus control). Restriction of energy intake by reduction of carbohydrate intake, lipid intake, or total diet produced a similar inhibition of growth of R3327-H or LNCaP tumors. These effects were associated with reduced circulating insulin-like growth factor-I.
CONCLUSIONS: Our observations are consistent with the hypothesis that energy restriction reduces prostate tumor growth by inhibiting tumor angiogenesis. Furthermore, dietary fat concentration does not influence prostate tumor growth when energy intake is reduced.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10088621     DOI: 10.1093/jnci/91.6.512

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  42 in total

1.  Dietary energy balance modulates prostate cancer progression in Hi-Myc mice.

Authors:  Jorge Blando; Tricia Moore; Stephen Hursting; Guiyu Jiang; Achinto Saha; Linda Beltran; Jianjun Shen; John Repass; Sara Strom; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-27

2.  Effect of isocaloric low fat diet on prostate cancer xenograft progression in a hormone deprivation model.

Authors:  Jessica C Lloyd; Jodi A Antonelli; Tameika E Phillips; Elizabeth M Masko; Jean-Alfred Thomas; Susan H M Poulton; Michael Pollak; Michael Pollack; Stephen J Freedland
Journal:  J Urol       Date:  2010-02-20       Impact factor: 7.450

3.  Complementary medicine for prostate cancer: effects of soy and fat consumption.

Authors:  M A Moyad; W A Sakr; D Hirano; G J Miller
Journal:  Rev Urol       Date:  2001

4.  Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2.

Authors:  Naoko Kobayashi; R James Barnard; Susanne M Henning; David Elashoff; Srinivasa T Reddy; Pinchas Cohen; Pak Leung; Jenny Hong-Gonzalez; Stephen J Freedland; Jonathan Said; Dorina Gui; Navindra P Seeram; Laura M Popoviciu; Dilprit Bagga; David Heber; John A Glaspy; William J Aronson
Journal:  Clin Cancer Res       Date:  2006-08-01       Impact factor: 12.531

Review 5.  The ketogenic diet for the treatment of malignant glioma.

Authors:  Eric C Woolf; Adrienne C Scheck
Journal:  J Lipid Res       Date:  2014-02-06       Impact factor: 5.922

6.  Prostate cancer: Is active surveillance safe for obese patients?

Authors:  Stephen Freedland; Lorelei Mucci
Journal:  Nat Rev Urol       Date:  2014-08-12       Impact factor: 14.432

7.  Carbohydrate restriction and lactate transporter inhibition in a mouse xenograft model of human prostate cancer.

Authors:  Howard S Kim; Elizabeth M Masko; Susan L Poulton; Kelly M Kennedy; Salvatore V Pizzo; Mark W Dewhirst; Stephen J Freedland
Journal:  BJU Int       Date:  2012-03-06       Impact factor: 5.588

8.  Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis.

Authors:  Stephen J Freedland; John Mavropoulos; Amy Wang; Medha Darshan; Wendy Demark-Wahnefried; William J Aronson; Pinchas Cohen; David Hwang; Bercedis Peterson; Timothy Fields; Salvatore V Pizzo; William B Isaacs
Journal:  Prostate       Date:  2008-01-01       Impact factor: 4.104

9.  Cancer as a metabolic disease.

Authors:  Thomas N Seyfried; Laura M Shelton
Journal:  Nutr Metab (Lond)       Date:  2010-01-27       Impact factor: 4.169

10.  Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model.

Authors:  P Mukherjee; M M El-Abbadi; J L Kasperzyk; M K Ranes; T N Seyfried
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.